Experimental and clinical studies with somatostatin analogue octreotide in small cell lung cancer

This publication has 38 references indexed in Scilit:

• Inhibition of growth of human breast carcinomas in vivo by somatostatin analog SMS 201-995: treatment of nude mouse xenografts.
  1989
• SOMATOSTATIN ANALOG SMS 201-995 REDUCES SERUM IGF-I LEVELS IN PATIENTS WITH NEOPLASMS POTENTIALLY DEPENDENT ON IGF-I
  1989
• Somatostatin and somatostatin analogues in oncology
  Cancer Treatment Reviews, 1989
• Somatostatin analogues inhibit growth of pancreatic cancer by stimulating tyrosine phosphatase.
  Proceedings of the National Academy of Sciences, 1989
• Somatostatin and Somatostatin Analogue (SMS 201-995) in Treatment of Hormone-Secreting Tumors of the Pituitary and Gastrointestinal Tract and Non-Neoplastic Diseases of the Gut
  Annals of Internal Medicine, 1989
• Neuron-specific enolase: How useful as a cancer marker?
  European Journal of Cancer and Clinical Oncology, 1988
• High affinity binding of [125I-Tyr11]somatostatin-14 to human small cell lung carcinoma (NCI-H69)
  Life Sciences, 1988
• SOMATOSTATIN RECEPTORS IN HUMAN ENDOCRINE TUMORS
  1987
• Treatment of the Malignant Carcinoid Syndrome
  New England Journal of Medicine, 1986
• The Measurement of Insulin-Like Growth Factor I: Clinical Applications and Significance
  Annals of Clinical Biochemistry: International Journal of Laboratory Medicine, 1986